← Browse by Condition
Medical Condition

cardiometabolic risk factors

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for cardiometabolic risk factors sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Top Sponsors
Fu Jen Catholic University Hospital 1 trial
Global Centre for Asian Women's Health 1 trial
Javier Marhuenda 1 trial
NCT07400367
Recruiting

Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Enrollment
80 pts
Location
Taiwan
Sponsor
Fu Jen Catholic University Hos...
View Trial →
NCT06825936
Recruiting

Asian-Mediterranean Diet and Women's Health

Enrollment
300 pts
Location
Singapore
Sponsor
Global Centre for Asian Women'...
View Trial →
NCT07433998
Recruiting

Effect of a Ginger-Based Beverage on Inflammation, Oxidative Stress, and Endothelial Function

Enrollment
50 pts
Location
Spain
Sponsor
Javier Marhuenda
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology